MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 263 filers reported holding MIRATI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $105,983 | +65.0% | 2,433,029 | +36.9% | 0.02% | +77.8% |
| Q2 2023 | $64,224 | -2.5% | 1,777,579 | +0.4% | 0.01% | -10.0% |
| Q1 2023 | $65,844 | +2.6% | 1,770,941 | +25.0% | 0.01% | 0.0% |
| Q4 2022 | $64,191 | -99.9% | 1,416,728 | +24.0% | 0.01% | -23.1% |
| Q3 2022 | $79,811,000 | +13.1% | 1,142,755 | +8.7% | 0.01% | +44.4% |
| Q2 2022 | $70,589,000 | -47.8% | 1,051,530 | -36.0% | 0.01% | -35.7% |
| Q1 2022 | $135,187,000 | -57.6% | 1,644,216 | -24.4% | 0.01% | -51.7% |
| Q4 2021 | $319,021,000 | -14.7% | 2,174,799 | +2.9% | 0.03% | -17.1% |
| Q3 2021 | $374,025,000 | +20.5% | 2,114,210 | +10.0% | 0.04% | +20.7% |
| Q2 2021 | $310,425,000 | +18.2% | 1,921,779 | +25.4% | 0.03% | +11.5% |
| Q1 2021 | $262,517,000 | -23.4% | 1,532,500 | -1.7% | 0.03% | -25.7% |
| Q4 2020 | $342,510,000 | +57.3% | 1,559,416 | +18.9% | 0.04% | +40.0% |
| Q3 2020 | $217,735,000 | +45.7% | 1,311,262 | +0.2% | 0.02% | +31.6% |
| Q2 2020 | $149,432,000 | +51.0% | 1,308,852 | +1.6% | 0.02% | +18.8% |
| Q1 2020 | $98,981,000 | -44.6% | 1,287,645 | -7.1% | 0.02% | -30.4% |
| Q4 2019 | $178,520,000 | +71.4% | 1,385,379 | +3.7% | 0.02% | +53.3% |
| Q3 2019 | $104,132,000 | -16.2% | 1,336,564 | +10.8% | 0.02% | -11.8% |
| Q2 2019 | $124,233,000 | +107.3% | 1,206,144 | +47.5% | 0.02% | +88.9% |
| Q1 2019 | $59,932,000 | +329.2% | 817,628 | +148.4% | 0.01% | +350.0% |
| Q4 2018 | $13,963,000 | -9.6% | 329,160 | +0.3% | 0.00% | 0.0% |
| Q3 2018 | $15,450,000 | +47.5% | 328,024 | +54.4% | 0.00% | 0.0% |
| Q2 2018 | $10,475,000 | +83.1% | 212,465 | +14.0% | 0.00% | +100.0% |
| Q1 2018 | $5,720,000 | – | 186,320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |